Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Beijing Konruns Pharmaceutical Co., Ltd.
🇨🇳
China
Country
🇨🇳
China
Ownership
Public
Established
2003-09-03
Employees
447
Market Cap
-
Website
http://www.konruns.cn
Clinical Trials
Related News
Kanitinib in Treating Patients With Advanced Solid Tumors
Phase 1
Completed
Conditions
Solid Tumors
Interventions
Drug: Kanitinib
Subscribe
First Posted Date
2016-09-27
Last Posted Date
2020-09-03
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
9
Registration Number
NCT02916095
Locations
🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy